HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
28:@0.083944:0.033217:0.104640:0.033217:0.104640:0.013052:0.083944:0.013052:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
statins: poison or panacea?:@0.076190:0.099847:0.527746:0.099847:0.527746:0.063183:0.076190:0.063183:0.017471:0.010079:0.022175:0.010079:0.008063:0.020159:0.014783:0.009407:0.009407:0.022175:0.021503:0.008063:0.014783:0.021503:0.020159:0.009407:0.021503:0.010751:0.009407:0.022175:0.022175:0.020159:0.022175:0.021503:0.021503:0.022175:0.018815
J singbo :@0.076190:0.169924:0.149434:0.169924:0.149434:0.151592:0.076190:0.151592:0.008063:0.004704:0.008735:0.004032:0.010079:0.011087:0.011087:0.010751:0.004704
MBChB, FCp (sA):@0.076190:0.182135:0.186217:0.182135:0.186217:0.168106:0.076190:0.168106:0.012351:0.007714:0.010926:0.008198:0.007714:0.003723:0.003723:0.006518:0.010926:0.007956:0.003723:0.004959:0.006693:0.009945:0.004959
Senior Registrar, Division of Endocrinology, Department:@0.076190:0.200269:0.431172:0.200269:0.431172:0.186240:0.076190:0.186240:0.006693:0.008735:0.008198:0.002688:0.008803:0.004045:0.003723:0.008158:0.008735:0.009045:0.002688:0.005214:0.004556:0.004045:0.009179:0.004045:0.003723:0.003723:0.009999:0.002688:0.007445:0.002688:0.005214:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.007203:0.008198:0.009206:0.008803:0.008695:0.004045:0.002688:0.008198:0.008803:0.002688:0.008803:0.009045:0.007203:0.003723:0.003723:0.009999:0.008735:0.009165:0.009179:0.004045:0.004556:0.012606:0.008735:0.008198:0.004556
of Medicine, University of Cape Town, Cape Town:@0.076190:0.213272:0.400410:0.213272:0.400410:0.199243:0.076190:0.199243:0.008803:0.004220:0.003723:0.012351:0.008735:0.009206:0.002688:0.008695:0.002688:0.008198:0.008735:0.003723:0.003723:0.008803:0.008198:0.002688:0.007445:0.008735:0.004045:0.005214:0.002688:0.004556:0.007203:0.003723:0.008803:0.004220:0.003723:0.010926:0.009179:0.009165:0.008735:0.003723:0.005725:0.008803:0.011168:0.008198:0.003723:0.003723:0.010926:0.009179:0.009165:0.008735:0.003723:0.005725:0.008803:0.011168:0.008198
DJ blom:@0.076190:0.237313:0.141034:0.237313:0.141034:0.218981:0.076190:0.218981:0.011759:0.008063:0.004704:0.009743:0.004032:0.010751:0.015791
MBChB, MMed, FCp (sA), phD.:@0.076190:0.249524:0.273625:0.249524:0.273625:0.235495:0.076190:0.235495:0.012351:0.007714:0.010926:0.008198:0.007714:0.003723:0.003723:0.012351:0.012351:0.008735:0.009206:0.003723:0.003723:0.006518:0.010926:0.007956:0.003723:0.004959:0.006693:0.009945:0.004959:0.003723:0.003723:0.007956:0.008198:0.009999:0.003723
Head of Division of Lipidology, Department of Medicine,:@0.076190:0.267658:0.440351:0.267658:0.440351:0.253629:0.076190:0.253629:0.009179:0.008735:0.009179:0.009206:0.003723:0.008803:0.004220:0.003723:0.009999:0.002688:0.007445:0.002688:0.005214:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.006209:0.002688:0.009165:0.002688:0.009206:0.008803:0.002688:0.008803:0.009045:0.007203:0.003723:0.003723:0.009999:0.008735:0.009165:0.009179:0.004045:0.004556:0.012606:0.008735:0.008198:0.004556:0.003723:0.008803:0.004220:0.003723:0.012351:0.008735:0.009206:0.002688:0.008695:0.002688:0.008198:0.008735:0.003723
University of Cape Town, Cape Town:@0.076190:0.280661:0.314923:0.280661:0.314923:0.266632:0.076190:0.266632:0.008803:0.008198:0.002688:0.007445:0.008735:0.004045:0.005214:0.002688:0.004556:0.007203:0.003723:0.008803:0.004220:0.003723:0.010926:0.009179:0.009165:0.008735:0.003723:0.005725:0.008803:0.011168:0.008198:0.003723:0.003723:0.010926:0.009179:0.009165:0.008735:0.003723:0.005725:0.008803:0.011168:0.008198
patients with dyslipidemias  are at an increased risk of :@0.076190:0.310723:0.485145:0.310723:0.485145:0.294940:0.076190:0.294940:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006486:0.012564:0.003024:0.005125:0.009223:0.006486:0.010357:0.008104:0.005866:0.003024:0.003024:0.010311:0.003024:0.010357:0.009827:0.014182:0.003024:0.010326:0.005866:0.004188:0.002313:0.010326:0.004551:0.009827:0.006486:0.010326:0.005125:0.006486:0.010326:0.009223:0.006486:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.006486:0.004551:0.003024:0.005866:0.007590:0.006486:0.009903:0.004747:0.004188
developing atherosclerotic cardiovascular disease (As-:@0.076190:0.325005:0.480942:0.325005:0.480942:0.309222:0.076190:0.309222:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.003024:0.009223:0.010175:0.004264:0.010326:0.005125:0.009223:0.009827:0.004551:0.009903:0.005866:0.009782:0.003024:0.009827:0.004551:0.009903:0.005125:0.003024:0.009782:0.004248:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004279:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004279:0.005579:0.011188:0.007529:0.005020
CVD). In the early 1990s, the availability of the 3-hydroxy-:@0.076190:0.339286:0.480942:0.339286:0.480942:0.323504:0.076190:0.323504:0.012292:0.010614:0.011249:0.005579:0.004188:0.003084:0.003417:0.009223:0.003069:0.005125:0.009223:0.009827:0.003069:0.009827:0.010326:0.004551:0.003024:0.008104:0.003084:0.008376:0.008376:0.008376:0.008376:0.005866:0.004188:0.003084:0.005125:0.009223:0.009827:0.003069:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.003099:0.009903:0.004747:0.003069:0.005125:0.009223:0.009827:0.003069:0.008376:0.005020:0.009223:0.008104:0.010357:0.004551:0.009903:0.007257:0.008104:0.005020
3-methylglutaryl coenzyme  A (HMG-CoA) reductase :@0.076190:0.353568:0.485145:0.353568:0.485145:0.337786:0.076190:0.337786:0.008376:0.005020:0.014182:0.009827:0.005125:0.009223:0.008104:0.003024:0.010175:0.003024:0.009192:0.005125:0.010326:0.004551:0.008104:0.003024:0.009525:0.009782:0.009903:0.009827:0.009223:0.006426:0.008104:0.014182:0.009827:0.004188:0.005322:0.011188:0.009525:0.005579:0.010326:0.013894:0.013184:0.005020:0.012292:0.009903:0.011188:0.005579:0.009525:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.010326:0.005866:0.009827:0.004188
inhibitors (“statins”) revolutionised the treatment of lipid :@0.076190:0.367850:0.485100:0.367850:0.485100:0.352067:0.076190:0.352067:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004626:0.005579:0.007590:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.007318:0.005579:0.004626:0.004551:0.009827:0.008376:0.009903:0.003024:0.009192:0.005125:0.003024:0.009903:0.009207:0.003024:0.005866:0.009827:0.010357:0.004626:0.005125:0.009223:0.009827:0.004626:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004611:0.009903:0.004747:0.004626:0.003024:0.003024:0.010311:0.003024:0.010357:0.004188
abnormalities and the prevention of AsCVD. With ever-:@0.076190:0.382132:0.480957:0.382132:0.480957:0.366349:0.076190:0.366349:0.010326:0.010311:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005125:0.003024:0.009827:0.005866:0.004490:0.010326:0.009223:0.010357:0.004490:0.005125:0.009223:0.009827:0.004475:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.004475:0.009903:0.004747:0.004475:0.011188:0.007529:0.012292:0.010614:0.011249:0.004188:0.004490:0.014514:0.003024:0.005125:0.009223:0.004490:0.009827:0.008376:0.009827:0.004551:0.005020
increasing evidence regarding their safety and effica:@0.076190:0.396413:0.475907:0.396413:0.475907:0.380631:0.076190:0.380631:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.003024:0.009223:0.010175:0.005760:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.005760:0.004551:0.009827:0.010175:0.010326:0.004551:0.010357:0.003024:0.009207:0.010175:0.005760:0.005125:0.009223:0.009827:0.003024:0.004551:0.005760:0.005866:0.010326:0.004747:0.009827:0.005125:0.008104:0.005760:0.010326:0.009223:0.010357:0.005760:0.009827:0.004747:0.003681:0.003681:0.009782:0.010326
-:@0.475907:0.396413:0.480927:0.396413:0.480927:0.380631:0.475907:0.380631:0.005020
cy, we have witnessed a remarkable growth in the num-:@0.076190:0.410695:0.480957:0.410695:0.480957:0.394912:0.076190:0.394912:0.009782:0.008104:0.004188:0.003387:0.012564:0.009827:0.003387:0.009223:0.010326:0.008376:0.009827:0.003387:0.012564:0.003024:0.005125:0.009223:0.009827:0.005866:0.005866:0.009827:0.010357:0.003387:0.010326:0.003387:0.004551:0.009827:0.014182:0.010326:0.004551:0.007590:0.010326:0.010311:0.003024:0.009827:0.003387:0.010175:0.004551:0.009903:0.012564:0.005125:0.009223:0.003372:0.003024:0.009223:0.003387:0.005125:0.009223:0.009827:0.003372:0.009223:0.009192:0.014182:0.005020
ber of patients eligible for statins, in addition to a move :@0.076190:0.424977:0.485130:0.424977:0.485130:0.409194:0.076190:0.409194:0.010311:0.009827:0.004551:0.004521:0.009903:0.004747:0.004521:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004521:0.009827:0.003024:0.003024:0.010175:0.003024:0.010311:0.003024:0.009827:0.004521:0.004747:0.009903:0.004551:0.004505:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004188:0.004521:0.003024:0.009223:0.004521:0.010326:0.010357:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.004521:0.005125:0.009903:0.004505:0.010326:0.004521:0.014182:0.009903:0.008376:0.009827:0.004188
towards lower low-density lipoprotein (LDL) cholesterol :@0.076190:0.439259:0.485145:0.439259:0.485145:0.423476:0.076190:0.423476:0.005125:0.009903:0.012564:0.010326:0.004551:0.010357:0.005866:0.005896:0.003024:0.009903:0.012564:0.009827:0.004551:0.005896:0.003024:0.009903:0.012564:0.005020:0.010357:0.009827:0.009223:0.005866:0.003024:0.005125:0.008104:0.005912:0.003024:0.003024:0.010311:0.009903:0.010311:0.004551:0.009903:0.005125:0.009827:0.003024:0.009223:0.005896:0.005579:0.006985:0.011249:0.006985:0.005579:0.005912:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188
targets and, consequently, higher statin doses. Despite :@0.076190:0.453540:0.485130:0.453540:0.485130:0.437758:0.076190:0.437758:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.005866:0.005020:0.010326:0.009223:0.010357:0.004188:0.005020:0.009782:0.009903:0.009223:0.005866:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.003024:0.008104:0.004188:0.005020:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.005020:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005020:0.010357:0.009903:0.005866:0.009827:0.005866:0.004188:0.005020:0.011249:0.009827:0.005866:0.010311:0.003024:0.005125:0.009827:0.004188
overwhelming proof of efficacy and safety, statins are :@0.076190:0.467822:0.485130:0.467822:0.485130:0.452039:0.076190:0.452039:0.009903:0.008376:0.009827:0.004551:0.012564:0.009223:0.009827:0.003024:0.014182:0.003024:0.009223:0.010175:0.005639:0.010311:0.004551:0.009903:0.009903:0.004747:0.005639:0.009903:0.004747:0.005639:0.009827:0.004747:0.003681:0.003681:0.009782:0.010326:0.009782:0.008104:0.005639:0.010326:0.009223:0.010357:0.005655:0.005866:0.010326:0.004747:0.009827:0.005125:0.008104:0.004188:0.005639:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.005655:0.010326:0.004551:0.009827:0.004188
still frequently utilised suboptimally and “statin phobia” :@0.076190:0.482104:0.485145:0.482104:0.485145:0.466321:0.076190:0.466321:0.005866:0.005125:0.003024:0.003024:0.003024:0.005397:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.003024:0.008104:0.005382:0.009192:0.005125:0.003024:0.003024:0.003024:0.005866:0.009827:0.010357:0.005397:0.005866:0.009192:0.010311:0.009903:0.010311:0.005125:0.003024:0.014182:0.010326:0.003024:0.003024:0.008104:0.005397:0.010326:0.009223:0.010357:0.005382:0.007590:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005382:0.010311:0.009223:0.009903:0.010311:0.003024:0.010326:0.007318:0.004188
is an important contributor to their underutilisation. :@0.076190:0.496385:0.447378:0.496385:0.447378:0.480603:0.076190:0.480603:0.003024:0.005866:0.004188:0.010326:0.009223:0.004188:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.005125:0.004188:0.009782:0.009903:0.009223:0.005125:0.004551:0.003024:0.010311:0.009192:0.005125:0.009903:0.004551:0.004188:0.005125:0.009903:0.004188:0.005125:0.009223:0.009827:0.003024:0.004551:0.004188:0.009192:0.009223:0.010357:0.009827:0.004551:0.009192:0.005125:0.003024:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188
statins act primarily by competitively inhibiting HMG-:@0.090478:0.510667:0.480957:0.510667:0.480957:0.494884:0.090478:0.494884:0.007529:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.005337:0.010326:0.009782:0.005125:0.005337:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.003024:0.003024:0.008104:0.005352:0.010311:0.008104:0.005352:0.009782:0.009903:0.014182:0.010311:0.009827:0.005125:0.003024:0.005125:0.003024:0.008376:0.009827:0.003024:0.008104:0.005352:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.003024:0.009223:0.010175:0.005352:0.010326:0.013894:0.013184:0.005020
CoA reductase, the rate-limiting enzyme in the choles-:@0.076190:0.524949:0.480972:0.524949:0.480972:0.509166:0.076190:0.509166:0.012292:0.009903:0.011188:0.005125:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.010326:0.005866:0.009827:0.004188:0.005125:0.005125:0.009223:0.009827:0.005125:0.004551:0.010326:0.005125:0.009827:0.005020:0.003024:0.003024:0.014182:0.003024:0.005125:0.003024:0.009223:0.010175:0.005125:0.009827:0.009223:0.006426:0.008104:0.014182:0.009827:0.005125:0.003024:0.009223:0.005125:0.005125:0.009223:0.009827:0.005125:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005020
terol synthetic pathway. Lower intracellular cholesterol :@0.076190:0.539231:0.485130:0.539231:0.485130:0.523448:0.076190:0.523448:0.005125:0.009827:0.004551:0.009903:0.003024:0.005594:0.005866:0.008104:0.009223:0.005125:0.009223:0.009827:0.005125:0.003024:0.009782:0.005594:0.010311:0.010326:0.005125:0.009223:0.012564:0.010326:0.008104:0.004188:0.005594:0.006985:0.009903:0.012564:0.009827:0.004551:0.005594:0.003024:0.009223:0.005125:0.004551:0.010326:0.009782:0.009827:0.003024:0.003024:0.009192:0.003024:0.010326:0.004551:0.005594:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188
results in the cell upregulating LDL-receptors, which in :@0.076190:0.553512:0.485145:0.553512:0.485145:0.537730:0.076190:0.537730:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.006410:0.003024:0.009223:0.006410:0.005125:0.009223:0.009827:0.006410:0.009782:0.009827:0.003024:0.003024:0.006410:0.009192:0.010311:0.004551:0.009827:0.010175:0.009192:0.003024:0.010326:0.005125:0.003024:0.009223:0.010175:0.006410:0.006985:0.011249:0.006985:0.005020:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.005866:0.004188:0.006395:0.012564:0.009223:0.003024:0.009782:0.009223:0.006410:0.003024:0.009223:0.004188
turn  leads to  the  lowering  of plasma LDL cholesterol. :@0.076190:0.567794:0.485145:0.567794:0.485145:0.552011:0.076190:0.552011:0.005125:0.009192:0.004551:0.009223:0.004188:0.003009:0.003024:0.009827:0.010326:0.010357:0.005866:0.007212:0.005125:0.009903:0.004188:0.003009:0.005125:0.009223:0.009827:0.004188:0.003009:0.003024:0.009903:0.012564:0.009827:0.004551:0.003024:0.009223:0.010175:0.004188:0.003009:0.009903:0.004747:0.007212:0.010311:0.003024:0.010326:0.005866:0.014182:0.010326:0.007212:0.006985:0.011249:0.006985:0.007212:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.004188
Inhibiting HMG-CoA  reductase also affects the  syn-:@0.076190:0.582076:0.480942:0.582076:0.480942:0.566293:0.076190:0.566293:0.003417:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.003024:0.009223:0.010175:0.009404:0.010326:0.013894:0.013184:0.005020:0.012292:0.009903:0.011188:0.004188:0.005201:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.010326:0.005866:0.009827:0.009404:0.010326:0.003024:0.005866:0.009903:0.009404:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.009404:0.005125:0.009223:0.009827:0.004188:0.005201:0.005866:0.008104:0.009223:0.005020
thesis of isoprenoids. Altered levels of isoprenoids and :@0.076190:0.596357:0.485145:0.596357:0.485145:0.580575:0.076190:0.580575:0.005125:0.009223:0.009827:0.005866:0.003024:0.005866:0.006410:0.009903:0.004747:0.006410:0.003024:0.005866:0.009903:0.010311:0.004551:0.009827:0.009223:0.009903:0.003024:0.010357:0.005866:0.004188:0.006410:0.011188:0.003024:0.005125:0.009827:0.004551:0.009827:0.010357:0.006410:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.006426:0.009903:0.004747:0.006410:0.003024:0.005866:0.009903:0.010311:0.004551:0.009827:0.009223:0.009903:0.003024:0.010357:0.005866:0.006410:0.010326:0.009223:0.010357:0.004188
changes  in protein  prenylation  may explain many of :@0.076190:0.610639:0.485130:0.610639:0.485130:0.594857:0.076190:0.594857:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.005866:0.004188:0.003145:0.003024:0.009223:0.007348:0.010311:0.004551:0.009903:0.005125:0.009827:0.003024:0.009223:0.004188:0.003145:0.010311:0.004551:0.009827:0.009223:0.008104:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003145:0.014182:0.010326:0.008104:0.007348:0.009827:0.007257:0.010311:0.003024:0.010326:0.003024:0.009223:0.007348:0.014182:0.010326:0.009223:0.008104:0.007348:0.009903:0.004747:0.004188
the effects of statins thought to be independent of lipid-:@0.076190:0.624921:0.480942:0.624921:0.480942:0.609138:0.076190:0.609138:0.005125:0.009223:0.009827:0.003613:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.003629:0.009903:0.004747:0.003613:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.003629:0.005125:0.009223:0.009903:0.009192:0.010175:0.009223:0.005125:0.003613:0.005125:0.009903:0.003629:0.010311:0.009827:0.003629:0.003024:0.009223:0.010357:0.009827:0.010311:0.009827:0.009223:0.010357:0.009827:0.009223:0.005125:0.003613:0.009903:0.004747:0.003613:0.003024:0.003024:0.010311:0.003024:0.010357:0.005020
lowering.  These so-called pleiotropic effects include a :@0.076190:0.639203:0.485144:0.639203:0.485144:0.623420:0.076190:0.623420:0.003024:0.009903:0.012564:0.009827:0.004551:0.003024:0.009223:0.010175:0.004188:0.004852:0.005277:0.006441:0.009223:0.009827:0.005866:0.009827:0.005277:0.005866:0.009903:0.005020:0.009782:0.010326:0.003024:0.003024:0.009827:0.010357:0.005277:0.010311:0.003024:0.009827:0.003024:0.009903:0.005125:0.004551:0.009903:0.010311:0.003024:0.009782:0.005277:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.005277:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.005277:0.010326:0.012184
1:@0.142661:0.633904:0.147519:0.633904:0.147519:0.624750:0.142661:0.624750:0.004858
beneficial influence on endothelial function; the stabili:@0.076189:0.653485:0.475906:0.653485:0.475906:0.637702:0.076189:0.637702:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.009782:0.003024:0.010326:0.003024:0.004717:0.003024:0.009223:0.003666:0.003666:0.009192:0.009827:0.009223:0.009782:0.009827:0.004717:0.009903:0.009223:0.004717:0.009827:0.009223:0.010357:0.009903:0.005125:0.009223:0.009827:0.003024:0.003024:0.010326:0.003024:0.004717:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004702:0.005125:0.009223:0.009827:0.004717:0.005866:0.005125:0.010326:0.010311:0.003024:0.003024:0.003024
-:@0.475937:0.653485:0.480956:0.653485:0.480956:0.637702:0.475937:0.637702:0.005020
sation of atherosclerotic plaques; anti-oxidative, anti-in-:@0.076189:0.667766:0.480941:0.667766:0.480941:0.651984:0.076189:0.651984:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.003931:0.009903:0.004747:0.003931:0.010326:0.005125:0.009223:0.009827:0.004551:0.009888:0.005866:0.009782:0.003024:0.009827:0.004551:0.009903:0.005125:0.003024:0.009782:0.003931:0.010311:0.003024:0.010326:0.010311:0.009192:0.009827:0.005866:0.004188:0.003931:0.010326:0.009223:0.005125:0.003024:0.005020:0.009903:0.007257:0.003024:0.010357:0.010326:0.005125:0.003024:0.008376:0.009827:0.004188:0.003931:0.010326:0.009223:0.005125:0.003024:0.005020:0.003024:0.009223:0.005020
flammatory and antithrombotic effects; and effects on :@0.076189:0.682048:0.485129:0.682048:0.485129:0.666265:0.076189:0.666265:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004823:0.010326:0.009223:0.010357:0.004823:0.010326:0.009223:0.005125:0.003024:0.005125:0.009223:0.004551:0.009903:0.014182:0.010311:0.009903:0.005110:0.003024:0.009782:0.004823:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.004823:0.010326:0.009223:0.010357:0.004823:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004823:0.009903:0.009223:0.004188
the immune system and bone metabolism. The clinical :@0.076189:0.696330:0.485114:0.696330:0.485114:0.680547:0.076189:0.680547:0.005125:0.009223:0.009827:0.005156:0.003024:0.014182:0.014182:0.009192:0.009223:0.009827:0.005156:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.005171:0.010326:0.009223:0.010357:0.005171:0.010311:0.009903:0.009223:0.009827:0.005156:0.014182:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.005866:0.014182:0.004188:0.005171:0.006441:0.009223:0.009827:0.005156:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188
importance of these pleiotropic effects – either benefi:@0.076189:0.710611:0.475937:0.710611:0.475937:0.694829:0.076189:0.694829:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.009782:0.009827:0.004929:0.009903:0.004747:0.004944:0.005125:0.009223:0.009827:0.005866:0.009827:0.004944:0.010311:0.003024:0.009827:0.003024:0.009903:0.005125:0.004551:0.009903:0.010311:0.003024:0.009782:0.004944:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004944:0.007560:0.004944:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.004929:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681
-:@0.475937:0.710611:0.480956:0.710611:0.480956:0.694829:0.475937:0.694829:0.005020
cial or harmful – is somewhat controversial. Neverthe-:@0.076189:0.724893:0.480956:0.724893:0.480956:0.709111:0.076189:0.709111:0.009782:0.003024:0.010326:0.003024:0.006410:0.009903:0.004551:0.006395:0.009223:0.010326:0.004551:0.014182:0.004747:0.009192:0.003024:0.006410:0.007560:0.006395:0.003024:0.005866:0.006410:0.005866:0.009903:0.014182:0.009827:0.012564:0.009223:0.010326:0.005125:0.006395:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.008376:0.009827:0.004551:0.005866:0.003024:0.010326:0.003024:0.004188:0.006395:0.011188:0.009827:0.008376:0.009827:0.004551:0.005125:0.009223:0.009827:0.005020
less, statins are being explored as potential treatments :@0.076189:0.739175:0.485174:0.739175:0.485174:0.723392:0.076189:0.723392:0.003024:0.009827:0.005866:0.005866:0.004188:0.005413:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.005413:0.010326:0.004551:0.009827:0.005413:0.010311:0.009827:0.003024:0.009223:0.010175:0.005413:0.009827:0.007257:0.010311:0.003024:0.009903:0.004551:0.009827:0.010357:0.005413:0.010326:0.005866:0.005413:0.010311:0.009903:0.005125:0.009827:0.009223:0.005125:0.003024:0.010326:0.003024:0.005413:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005866:0.004188
in  such  inflammatory  disorders  as  systemic  lupus  ery:@0.076189:0.753457:0.475921:0.753457:0.475921:0.737674:0.076189:0.737674:0.003024:0.009223:0.004188:0.003644:0.005866:0.009192:0.009782:0.009223:0.004188:0.003644:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.003629:0.010357:0.003024:0.005866:0.009903:0.004551:0.010357:0.009827:0.004551:0.005866:0.004188:0.003644:0.010326:0.005866:0.004188:0.003644:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.003024:0.009782:0.004188:0.003644:0.003024:0.009192:0.010311:0.009192:0.005866:0.004188:0.003644:0.009827:0.004551:0.008104
-:@0.475921:0.753457:0.480941:0.753457:0.480941:0.737674:0.475921:0.737674:0.005020
thematosus and rheumatoid arthritis. Reduction of LDL :@0.076189:0.767738:0.485129:0.767738:0.485129:0.751956:0.076189:0.751956:0.005125:0.009223:0.009827:0.014182:0.010326:0.005125:0.009903:0.005866:0.009192:0.005866:0.005670:0.010326:0.009223:0.010357:0.005670:0.004551:0.009223:0.009827:0.009192:0.014182:0.010326:0.005125:0.009903:0.003024:0.010357:0.005670:0.010326:0.004551:0.005125:0.009223:0.004551:0.003024:0.005125:0.003024:0.005866:0.004188:0.005670:0.009177:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.005670:0.009903:0.004747:0.005670:0.006985:0.011249:0.006985:0.004188
cholesterol seems to be the primary mechanism respon-:@0.076189:0.782020:0.480941:0.782020:0.480941:0.766237:0.076189:0.766237:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.003477:0.005866:0.009827:0.009827:0.014182:0.005866:0.003492:0.005125:0.009903:0.003477:0.010311:0.009827:0.003492:0.005125:0.009223:0.009827:0.003477:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.003492:0.014182:0.009827:0.009782:0.009223:0.010326:0.009223:0.003024:0.005866:0.014182:0.003492:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005020
sible for cardiovascular risk reduction as there is a close :@0.076189:0.796302:0.485114:0.796302:0.485114:0.780519:0.076189:0.780519:0.005866:0.003024:0.010311:0.003024:0.009827:0.004430:0.004747:0.009903:0.004536:0.004415:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004415:0.004551:0.003024:0.005866:0.007590:0.004415:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004415:0.010326:0.005866:0.004415:0.005125:0.009223:0.009827:0.004551:0.009827:0.004400:0.003024:0.005866:0.004415:0.010326:0.004415:0.009782:0.003024:0.009903:0.005866:0.009827:0.004188
relationship between the degree of LDL cholesterol re-:@0.076189:0.810583:0.480941:0.810583:0.480941:0.794801:0.076189:0.794801:0.004551:0.009827:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.009223:0.003024:0.010311:0.005231:0.010311:0.009827:0.005125:0.012564:0.009827:0.009827:0.009223:0.005216:0.005125:0.009223:0.009827:0.005216:0.010357:0.009827:0.010175:0.004551:0.009827:0.009827:0.005216:0.009903:0.004747:0.005231:0.006985:0.011249:0.006985:0.005231:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.005216:0.004551:0.009827:0.005020
duction and cardiovascular event reduction. Addition-:@0.076189:0.824865:0.480956:0.824865:0.480956:0.809083:0.076189:0.809083:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004823:0.010326:0.009223:0.010357:0.004823:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.004823:0.009827:0.008376:0.009827:0.009223:0.005125:0.004823:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004808:0.011188:0.010357:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.005020
ally, equivalent reductions in LDL cholesterol generally :@0.076189:0.839147:0.485144:0.839147:0.485144:0.823364:0.076189:0.823364:0.010326:0.003024:0.003024:0.008104:0.004188:0.005912:0.009827:0.010311:0.009192:0.003024:0.008376:0.010326:0.003024:0.009827:0.009223:0.005125:0.005896:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.005866:0.005896:0.003024:0.009223:0.005896:0.006985:0.011249:0.006985:0.005896:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.005896:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.003024:0.008104:0.004188
reduce cardiovascular event rates, irrespective of the :@0.076189:0.853429:0.485144:0.853429:0.485144:0.837646:0.076189:0.837646:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.006108:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.006123:0.009827:0.008376:0.009827:0.009223:0.005125:0.006108:0.004551:0.010326:0.005125:0.009827:0.005866:0.004188:0.006108:0.003024:0.004551:0.004551:0.009827:0.005866:0.010311:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.006108:0.009903:0.004747:0.006108:0.005125:0.009223:0.009827:0.004188
LDL-lowering mechanism.:@0.076189:0.867710:0.262728:0.867710:0.262728:0.851928:0.076189:0.851928:0.006985:0.011249:0.006985:0.005020:0.003024:0.009903:0.012564:0.009827:0.004551:0.003024:0.009223:0.010175:0.004188:0.014182:0.009827:0.009782:0.009223:0.010326:0.009223:0.003024:0.005866:0.014182:0.004188
siDe effeCts AnD stAtin PHObiA:@0.076190:0.900739:0.368895:0.900739:0.368895:0.880575:0.076190:0.880575:0.009609:0.005174:0.012935:0.009609:0.005174:0.009609:0.008870:0.008870:0.009609:0.014413:0.007761:0.009609:0.005174:0.013674:0.013674:0.012935:0.005174:0.009609:0.007761:0.013674:0.007761:0.005174:0.013674:0.005174:0.010348:0.012566:0.015522:0.010718:0.005174:0.013674
Despite  overwhelming  proof  of  efficacy  and  safety, :@0.076190:0.916799:0.485115:0.916799:0.485115:0.901017:0.076190:0.901017:0.011249:0.009827:0.005866:0.010311:0.003024:0.005125:0.009827:0.004188:0.004747:0.009903:0.008376:0.009827:0.004551:0.012564:0.009223:0.009827:0.003024:0.014182:0.003024:0.009223:0.010175:0.004188:0.004732:0.010311:0.004551:0.009903:0.009903:0.004732:0.004188:0.004732:0.009903:0.004747:0.004188:0.004732:0.009827:0.004747:0.003681:0.003681:0.009782:0.010326:0.009782:0.008104:0.004188:0.004732:0.010326:0.009223:0.010357:0.004188:0.004732:0.005866:0.010326:0.004747:0.009827:0.005125:0.008104:0.004188:0.004188
many patients and some  clinicians fear  the  use of :@0.076190:0.931081:0.485130:0.931081:0.485130:0.915298:0.076190:0.915298:0.014182:0.010326:0.009223:0.008104:0.009374:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.009374:0.010326:0.009223:0.010357:0.009374:0.005866:0.009903:0.014182:0.009827:0.004188:0.005171:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.003024:0.010326:0.009223:0.005866:0.009374:0.004747:0.009827:0.010326:0.004551:0.004188:0.005171:0.005125:0.009223:0.009827:0.004188:0.005171:0.009192:0.005866:0.009827:0.009374:0.009903:0.004747:0.004188
statins. statins are frequently perceived as highly toxic :@0.076190:0.945363:0.485160:0.945363:0.485160:0.929580:0.076190:0.929580:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004188:0.005896:0.007529:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.005896:0.010326:0.004551:0.009827:0.005881:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.003024:0.008104:0.005881:0.010311:0.009827:0.004551:0.009782:0.009827:0.003024:0.008376:0.009827:0.010357:0.005896:0.010326:0.005866:0.005896:0.009223:0.003024:0.010175:0.009223:0.003024:0.008104:0.005896:0.005125:0.009903:0.007257:0.003024:0.009782:0.004188
and dangerous drugs – for example, a Google search :@0.519042:0.168573:0.927982:0.168573:0.927982:0.152791:0.519042:0.152791:0.010326:0.009223:0.010357:0.005458:0.010357:0.010326:0.009223:0.010175:0.009827:0.004551:0.009903:0.009192:0.005866:0.005458:0.010357:0.004551:0.009192:0.010175:0.005866:0.005458:0.007560:0.005458:0.004747:0.009903:0.004551:0.005458:0.009827:0.007257:0.010326:0.014182:0.010311:0.003024:0.009827:0.004188:0.005458:0.010326:0.005458:0.013184:0.009903:0.009903:0.010175:0.003024:0.009827:0.005458:0.005866:0.009827:0.010326:0.004551:0.009782:0.009223:0.004188
(14  Jan 2019)  using the term “statin side  effect” had :@0.519042:0.182774:0.927997:0.182774:0.927997:0.166992:0.519042:0.166992:0.005579:0.008376:0.008376:0.004188:0.002994:0.007287:0.010326:0.009223:0.007166:0.008376:0.008376:0.008376:0.008376:0.005579:0.004188:0.002994:0.009192:0.005866:0.003024:0.009223:0.010175:0.007166:0.005125:0.009223:0.009827:0.007166:0.005125:0.009827:0.004551:0.014182:0.007166:0.007590:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.007166:0.005866:0.003024:0.010357:0.009827:0.004188:0.002994:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.007318:0.007166:0.009223:0.010326:0.010357:0.004188
more than 26 million hits. some of the most commonly :@0.519042:0.196975:0.927982:0.196975:0.927982:0.181192:0.519042:0.181192:0.014182:0.009903:0.004551:0.009827:0.005458:0.005125:0.009223:0.010326:0.009223:0.005473:0.008376:0.008376:0.005473:0.014182:0.003024:0.003024:0.003024:0.003024:0.009903:0.009223:0.005473:0.009223:0.003024:0.005125:0.005866:0.004188:0.005458:0.007529:0.009903:0.014182:0.009827:0.005458:0.009903:0.004747:0.005458:0.005125:0.009223:0.009827:0.005458:0.014182:0.009903:0.005866:0.005125:0.005458:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.003024:0.008104:0.004188
perceived problems include::@0.519042:0.211176:0.729892:0.211176:0.729892:0.195393:0.519042:0.195393:0.010311:0.009827:0.004551:0.009782:0.009827:0.003024:0.008376:0.009827:0.010357:0.004188:0.010311:0.004551:0.009903:0.010311:0.003024:0.009827:0.014182:0.005866:0.004188:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.004188
neurocognitive problems:@0.519047:0.242431:0.725338:0.242431:0.725338:0.224100:0.519047:0.224100:0.012431:0.010751:0.010079:0.005376:0.010751:0.010751:0.010751:0.011087:0.010079:0.004032:0.005040:0.004032:0.009407:0.010751:0.004704:0.011087:0.005376:0.010751:0.011087:0.004032:0.010751:0.015791:0.007392
Case reports, social media and the popular press have :@0.519047:0.258801:0.928002:0.258801:0.928002:0.243019:0.519047:0.243019:0.012292:0.010326:0.005866:0.009827:0.004581:0.004551:0.009827:0.010311:0.009903:0.004551:0.005125:0.005866:0.004188:0.004566:0.005866:0.009903:0.009782:0.003024:0.010326:0.003024:0.004581:0.014182:0.009827:0.010357:0.003024:0.010326:0.004581:0.010326:0.009223:0.010357:0.004581:0.005125:0.009223:0.009827:0.004566:0.010311:0.009903:0.010311:0.009192:0.003024:0.010326:0.004551:0.004581:0.010311:0.004551:0.009827:0.005866:0.005866:0.004581:0.009223:0.010326:0.008376:0.009827:0.004188
raised concerns about cognitive adverse events, such :@0.519047:0.273002:0.928002:0.273002:0.928002:0.257220:0.519047:0.257220:0.004551:0.010326:0.003024:0.005866:0.009827:0.010357:0.005624:0.009782:0.009903:0.009223:0.009782:0.009827:0.004551:0.009207:0.005866:0.005624:0.010326:0.010311:0.009903:0.009192:0.005125:0.005624:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.005624:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.005624:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.004188:0.005609:0.005866:0.009192:0.009782:0.009223:0.004188
as cognitive dysfunction, memory loss, severe irritability, :@0.519047:0.287203:0.927972:0.287203:0.927972:0.271421:0.519047:0.271421:0.010326:0.005866:0.004354:0.009782:0.009903:0.010175:0.009207:0.003024:0.005125:0.003024:0.008376:0.009827:0.004354:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004339:0.014182:0.009827:0.014182:0.009903:0.004551:0.008104:0.004339:0.003024:0.009903:0.005866:0.005866:0.004188:0.004354:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.004354:0.003024:0.004551:0.004551:0.003024:0.005125:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188:0.004188
aggression,  confusion,  suicide attempts and depres-:@0.519047:0.301404:0.923814:0.301404:0.923814:0.285622:0.519047:0.285622:0.010326:0.010175:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.004188:0.004596:0.009782:0.009903:0.009223:0.004747:0.009192:0.005866:0.003024:0.009903:0.009223:0.004188:0.004188:0.004596:0.005866:0.009192:0.003024:0.009782:0.003024:0.010357:0.009827:0.008799:0.010326:0.005125:0.005125:0.009827:0.014182:0.010311:0.005125:0.005866:0.008799:0.010326:0.009223:0.010357:0.008799:0.010357:0.009827:0.010311:0.004551:0.009827:0.005866:0.005020
sion, that apparently improved upon discontinuation :@0.519047:0.315605:0.927987:0.315605:0.927987:0.299822:0.519047:0.299822:0.005866:0.003024:0.009903:0.009223:0.004188:0.008028:0.005125:0.009223:0.010326:0.005125:0.008028:0.010326:0.010311:0.010311:0.010326:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.008028:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.010357:0.008028:0.009192:0.010311:0.009903:0.009223:0.008028:0.010357:0.003024:0.005866:0.009782:0.009903:0.009223:0.005125:0.003024:0.009223:0.009192:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
of statins.  This fear surrounding the potential cogni-:@0.519047:0.329806:0.923793:0.329793:0.923793:0.314010:0.519047:0.314023:0.009903:0.004747:0.007469:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004188:0.012634:0.007469:0.006441:0.009223:0.003024:0.005866:0.007469:0.004747:0.009827:0.010326:0.004551:0.007469:0.005866:0.009192:0.004551:0.004551:0.009888:0.009192:0.009223:0.010357:0.003024:0.009223:0.010175:0.007469:0.005125:0.009223:0.009827:0.007469:0.010311:0.009903:0.005125:0.009827:0.009223:0.005125:0.003024:0.010326:0.003024:0.007469:0.009782:0.009903:0.010175:0.009223:0.003024:-0.020454
2-4:@0.589913:0.324494:0.602540:0.324494:0.602540:0.315340:0.589913:0.315340:0.004858:0.002911:0.004858
tive side effects of statins was exacerbated by the FDA, :@0.519042:0.343994:0.927981:0.343994:0.927981:0.328211:0.519042:0.328211:0.005125:0.003024:0.008376:0.009827:0.004158:0.005866:0.003024:0.010357:0.009827:0.004158:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004158:0.009903:0.004747:0.004143:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004158:0.012564:0.010326:0.005866:0.004158:0.009827:0.007257:0.010326:0.009782:0.009827:0.004551:0.010311:0.010326:0.005125:0.009827:0.010357:0.004143:0.010311:0.008104:0.004158:0.005125:0.009223:0.009827:0.004143:0.007333:0.011249:0.011188:0.004188:0.004188
which in 2012 ruled that an additional warning be in-:@0.519042:0.358195:0.923793:0.358195:0.923793:0.342412:0.519042:0.342412:0.012564:0.009223:0.003024:0.009782:0.009223:0.006410:0.003024:0.009223:0.006410:0.008376:0.008376:0.008376:0.008376:0.006426:0.004551:0.009192:0.003024:0.009827:0.010357:0.006410:0.005125:0.009223:0.010326:0.005125:0.006410:0.010326:0.009223:0.006410:0.010326:0.010357:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.006410:0.012564:0.010326:0.004551:0.009223:0.003024:0.009223:0.010175:0.006410:0.010311:0.009827:0.006410:0.003024:0.009223:0.005020
cluded in the package insert of statins, indicating that :@0.519042:0.372395:0.927996:0.372395:0.927996:0.356613:0.519042:0.356613:0.009782:0.003024:0.009192:0.010357:0.009827:0.010357:0.005428:0.003024:0.009223:0.005428:0.005125:0.009223:0.009827:0.005413:0.010311:0.010326:0.009782:0.007590:0.010326:0.010175:0.009827:0.005428:0.003024:0.009223:0.005866:0.009827:0.004551:0.005125:0.005413:0.009903:0.004747:0.005413:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004188:0.005428:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009223:0.010175:0.005428:0.005125:0.009223:0.010326:0.005125:0.004188
statins may have adverse effects on cognition.  How-:@0.519042:0.386596:0.923778:0.386596:0.923778:0.370814:0.519042:0.370814:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.007182:0.014182:0.010326:0.008104:0.007182:0.009223:0.010326:0.008376:0.009827:0.007182:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.007182:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.007182:0.009903:0.009223:0.007182:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.002978:0.010326:0.009903:0.012564:0.005020
ever,  this FDA decision was not  supported by reliable :@0.519042:0.400797:0.927981:0.400797:0.927981:0.385015:0.519042:0.385015:0.009827:0.008376:0.009827:0.004551:0.004188:0.004188:0.002449:0.005125:0.009223:0.003024:0.005866:0.006652:0.007333:0.011249:0.011188:0.006652:0.010357:0.009827:0.009782:0.003024:0.005866:0.003024:0.009903:0.009223:0.006652:0.012564:0.010326:0.005866:0.006652:0.009223:0.009903:0.005125:0.004188:0.002449:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125:0.009827:0.010357:0.006652:0.010311:0.008104:0.006652:0.004551:0.009827:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188
data. For  instance,  a study of spontaneous  reports  of :@0.519042:0.414998:0.928012:0.414998:0.928012:0.399216:0.519042:0.399216:0.010357:0.010326:0.005125:0.010326:0.004188:0.006622:0.007333:0.009903:0.004551:0.004188:0.002419:0.003024:0.009223:0.005866:0.005125:0.010326:0.009223:0.009782:0.009827:0.004188:0.004188:0.002419:0.010326:0.006622:0.005866:0.005125:0.009192:0.010357:0.008104:0.006622:0.009903:0.004747:0.006622:0.005866:0.010311:0.009903:0.009223:0.005125:0.010326:0.009223:0.009827:0.009903:0.009192:0.005866:0.004188:0.002419:0.004551:0.009827:0.010311:0.009903:0.004551:0.005125:0.005866:0.004188:0.002419:0.009903:0.004747:0.004188
cognitive adverse events for statins in the FDA data-:@0.519042:0.429199:0.923778:0.429199:0.923778:0.413416:0.519042:0.413416:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.007227:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.007227:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.007227:0.004747:0.009903:0.004536:0.007227:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.007227:0.003024:0.009223:0.007227:0.005125:0.009223:0.009827:0.007227:0.007333:0.011249:0.011188:0.007227:0.010357:0.010326:0.005125:0.010326:0.005020
base showed that the frequency  of such reports  was :@0.519042:0.443400:0.927996:0.443400:0.927996:0.427617:0.519042:0.427617:0.010311:0.010326:0.005866:0.009827:0.006698:0.005866:0.009223:0.009903:0.012564:0.009827:0.010357:0.006698:0.005125:0.009223:0.010326:0.005125:0.006698:0.005125:0.009223:0.009827:0.006698:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.009782:0.008104:0.004188:0.002495:0.009903:0.004747:0.006698:0.005866:0.009192:0.009782:0.009223:0.006698:0.004551:0.009827:0.010311:0.009903:0.004551:0.005125:0.005866:0.004188:0.002495:0.012564:0.010326:0.005866:0.004188
very similar to those for other drugs used in the manage-:@0.519042:0.457601:0.923793:0.457601:0.923793:0.441818:0.519042:0.441818:0.008376:0.009827:0.004551:0.008104:0.003629:0.005866:0.003024:0.014182:0.003024:0.003024:0.010326:0.004551:0.003629:0.005125:0.009903:0.003613:0.005125:0.009223:0.009903:0.005866:0.009827:0.003613:0.004747:0.009903:0.004551:0.003613:0.009903:0.005125:0.009223:0.009827:0.004551:0.003613:0.010357:0.004551:0.009192:0.010175:0.005866:0.003629:0.009192:0.005866:0.009827:0.010357:0.003629:0.003024:0.009223:0.003629:0.005125:0.009223:0.009827:0.003613:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.005020
ment of AsCVD. Between November 1997 and February :@0.519042:0.471802:0.927981:0.471802:0.927981:0.456019:0.519042:0.456019:0.014182:0.009827:0.009223:0.005125:0.003402:0.009903:0.004747:0.003402:0.011188:0.007529:0.012292:0.010614:0.011249:0.004188:0.003402:0.008678:0.009827:0.005125:0.012564:0.009827:0.009827:0.009223:0.003402:0.011188:0.009903:0.008376:0.009827:0.014182:0.010311:0.009827:0.004551:0.003402:0.008376:0.008376:0.008376:0.008376:0.003417:0.010326:0.009223:0.010357:0.003417:0.007333:0.009827:0.010311:0.004551:0.009192:0.010326:0.004551:0.008104:0.004188
2002, there were 60 reports of patients who had memo-:@0.519042:0.486003:0.923808:0.486003:0.923808:0.470220:0.519042:0.470220:0.008376:0.008376:0.008376:0.008376:0.004188:0.004082:0.005125:0.009223:0.009827:0.004551:0.009827:0.004067:0.012564:0.009827:0.004551:0.009827:0.004082:0.008376:0.008376:0.004082:0.004551:0.009827:0.010311:0.009903:0.004551:0.005125:0.005866:0.004067:0.009903:0.004747:0.004067:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004082:0.012564:0.009223:0.009903:0.004067:0.009223:0.010326:0.010357:0.004082:0.014182:0.009827:0.014182:0.009903:0.005020
ry loss attributed to statin use in the FDA database.  This :@0.519042:0.500204:0.928003:0.500172:0.928003:0.484389:0.519042:0.484421:0.004551:0.008104:0.004354:0.003024:0.009903:0.005866:0.005866:0.004369:0.010326:0.005125:0.005125:0.004551:0.003024:0.010311:0.009192:0.005125:0.009827:0.010357:0.004369:0.005125:0.009903:0.004354:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.004369:0.009192:0.005866:0.009827:0.004369:0.003024:0.009223:0.004369:0.005125:0.009223:0.009827:0.004354:0.007333:0.011249:0.011188:0.004354:0.010357:0.010326:0.005125:0.010326:0.010311:0.010326:0.005866:0.009827:0.004188:0.004860:0.004369:0.006441:0.009223:0.003024:0.005866:-0.248611
5:@0.890032:0.494873:0.894890:0.494873:0.894890:0.485719:0.890032:0.485719:0.004858
is equivalent to 1.9 cases of cognitive adverse events :@0.519048:0.514373:0.927973:0.514373:0.927973:0.498590:0.519048:0.498590:0.003024:0.005866:0.006184:0.009827:0.010311:0.009192:0.003024:0.008376:0.010326:0.003024:0.009827:0.009223:0.005125:0.006184:0.005125:0.009903:0.006184:0.008376:0.004188:0.008376:0.006184:0.009782:0.010326:0.005866:0.009827:0.005866:0.006184:0.009903:0.004747:0.006184:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.006184:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.006184:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.004188
per million statin prescriptions, identical to the rate for :@0.519048:0.528574:0.928003:0.528574:0.928003:0.512791:0.519048:0.512791:0.010311:0.009827:0.004551:0.006063:0.014182:0.003024:0.003024:0.003024:0.003024:0.009903:0.009223:0.006063:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.006063:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.006063:0.003024:0.010357:0.009827:0.009223:0.005125:0.003024:0.009782:0.010326:0.003024:0.006063:0.005125:0.009903:0.006063:0.005125:0.009223:0.009827:0.006048:0.004551:0.010326:0.005125:0.009827:0.006063:0.004747:0.009903:0.004551:0.004188
clopidogrel and virtually the same as the 1.6-cases-per-:@0.519048:0.542775:0.923800:0.542775:0.923800:0.526992:0.519048:0.526992:0.009782:0.003024:0.009903:0.010311:0.003024:0.010357:0.009903:0.010175:0.004551:0.009827:0.003024:0.004158:0.010326:0.009223:0.010357:0.004158:0.008376:0.003024:0.004551:0.005125:0.009192:0.010326:0.003024:0.003024:0.008104:0.004173:0.005125:0.009223:0.009827:0.004158:0.005866:0.010326:0.014182:0.009827:0.004158:0.010326:0.005866:0.004158:0.005125:0.009223:0.009827:0.004158:0.008376:0.004188:0.008376:0.005020:0.009782:0.010326:0.005866:0.009827:0.005866:0.005020:0.010311:0.009827:0.004551:0.005020
million rate for losartan.  Although there has been some :@0.519048:0.556976:0.928001:0.556965:0.928001:0.541182:0.519048:0.541193:0.014182:0.003024:0.003024:0.003024:0.003024:0.009903:0.009223:0.004127:0.004551:0.010326:0.005125:0.009827:0.004112:0.004747:0.009903:0.004551:0.004112:0.003024:0.009903:0.005866:0.010326:0.004551:0.005125:0.010326:0.009223:0.004188:0.004866:0.004127:0.011188:0.003024:0.005125:0.009223:0.009903:0.009192:0.010175:0.009223:0.004112:0.005125:0.009223:0.009827:0.004551:0.009827:0.004112:0.009223:0.010326:0.005866:0.004127:0.010311:0.009827:0.009827:0.009223:0.004112:0.005866:0.009903:0.014182:0.009827:-0.322980
6:@0.688373:0.551666:0.693231:0.551666:0.693231:0.542513:0.688373:0.542513:0.004858
debate in the literature,  with some  studies reporting :@0.519046:0.571166:0.928031:0.571166:0.928031:0.555383:0.519046:0.555383:0.010357:0.009827:0.010311:0.010326:0.005125:0.009827:0.008315:0.003024:0.009223:0.008315:0.005125:0.009223:0.009827:0.008315:0.003024:0.003024:0.005125:0.009827:0.004551:0.010326:0.005125:0.009192:0.004551:0.009827:0.004188:0.004188:0.004112:0.012564:0.003024:0.005125:0.009223:0.008315:0.005866:0.009903:0.014182:0.009827:0.004188:0.004112:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.008315:0.004551:0.009827:0.010311:0.009903:0.004551:0.005125:0.003024:0.009223:0.010175:0.004188
mild cognitive dysfunction, as measured by neuropsy-:@0.519046:0.585367:0.923813:0.585367:0.923813:0.569584:0.519046:0.569584:0.014182:0.003024:0.003024:0.010357:0.006048:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.006048:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.006032:0.010326:0.005866:0.006048:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.010357:0.006032:0.010311:0.008104:0.006048:0.009223:0.009827:0.009192:0.004551:0.009903:0.010311:0.005866:0.008104:0.005020
chological testing:@0.519046:0.599568:0.651171:0.599568:0.651171:0.583785:0.519046:0.583785:0.009782:0.009223:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.005594:0.005125:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175
7,8:@0.651164:0.594261:0.663309:0.594261:0.663309:0.585107:0.651164:0.585107:0.004858:0.002429:0.004858
, and others not finding any cogni:@0.663311:0.599560:0.918792:0.599560:0.918792:0.583777:0.663311:0.583777:0.004188:0.005594:0.010326:0.009223:0.010357:0.005594:0.009903:0.005125:0.009223:0.009812:0.004551:0.005866:0.005594:0.009223:0.009903:0.005125:0.005579:0.003681:0.003681:0.009223:0.010357:0.003024:0.009223:0.010175:0.005579:0.010326:0.009223:0.008104:0.005594:0.009782:0.009903:0.010175:0.009223:0.003024
-:@0.918792:0.599560:0.923812:0.599560:0.923812:0.583777:0.918792:0.583777:0.005020
tive  impairment  in  either  cognitively normal  patients :@0.519045:0.613761:0.927985:0.613761:0.927985:0.597978:0.519045:0.597978:0.005125:0.003024:0.008376:0.009827:0.004188:0.004339:0.003024:0.014182:0.010311:0.010326:0.003024:0.004551:0.014182:0.009827:0.009223:0.005125:0.004188:0.004339:0.003024:0.009223:0.004188:0.004339:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.004188:0.004339:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.003024:0.008104:0.008542:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.004188:0.004339:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188
or  those  with  Alzheimer’s  disease, the  balance of  the :@0.519045:0.627962:0.928000:0.627962:0.928000:0.612179:0.519045:0.612179:0.009903:0.004551:0.004188:0.002419:0.005125:0.009223:0.009903:0.005866:0.009827:0.004188:0.002419:0.012564:0.003024:0.005125:0.009223:0.004188:0.002419:0.011188:0.003024:0.006426:0.009223:0.009827:0.003024:0.014182:0.009827:0.004551:0.005307:0.005866:0.004188:0.002419:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.006622:0.005125:0.009223:0.009827:0.004188:0.002419:0.010311:0.010326:0.003024:0.010326:0.009223:0.009782:0.009827:0.006622:0.009903:0.004747:0.004188:0.002419:0.005125:0.009223:0.009827:0.004188
evidence does not suggest that statins cause cognitive :@0.519045:0.642163:0.927985:0.642163:0.927985:0.626380:0.519045:0.626380:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004324:0.010357:0.009903:0.009827:0.005866:0.004324:0.009223:0.009903:0.005125:0.004324:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.004324:0.005125:0.009223:0.010326:0.005125:0.004324:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004324:0.009782:0.010326:0.009192:0.005866:0.009827:0.004324:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.004188
dysfunction. The Heart protection study was the largest :@0.519045:0.656364:0.928000:0.656364:0.928000:0.640581:0.519045:0.640581:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004687:0.006441:0.009223:0.009827:0.004687:0.010326:0.009827:0.010326:0.004551:0.005125:0.004702:0.008950:0.004551:0.009903:0.005125:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004672:0.007529:0.005125:0.009192:0.010357:0.008104:0.004702:0.012564:0.010326:0.005866:0.004702:0.005125:0.009223:0.009827:0.004687:0.003024:0.010326:0.004551:0.010175:0.009827:0.005866:0.005125:0.004188
double-blind, placebo-controlled,  randomised trial to :@0.519045:0.670564:0.927985:0.670564:0.927985:0.654782:0.519045:0.654782:0.010357:0.009903:0.009192:0.010311:0.003024:0.009827:0.005020:0.010311:0.003024:0.003024:0.009223:0.010357:0.004188:0.007726:0.010311:0.003024:0.010326:0.009782:0.009827:0.010311:0.009903:0.005020:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.003024:0.009827:0.010357:0.004188:0.004188:0.003523:0.004551:0.010326:0.009223:0.010357:0.009903:0.014182:0.003024:0.005866:0.009827:0.010357:0.007726:0.005125:0.004551:0.003024:0.010326:0.003024:0.007726:0.005125:0.009903:0.004188
systematically assess memory in statin-treated patients. :@0.519045:0.684765:0.928000:0.684765:0.928000:0.668983:0.519045:0.668983:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.010326:0.005125:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.004929:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.004914:0.014182:0.009827:0.014182:0.009903:0.004551:0.008104:0.004914:0.003024:0.009223:0.004914:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005020:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.004914:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.004188
Memory was  assessed  using a validated  telephonic :@0.519045:0.698966:0.928000:0.698966:0.928000:0.683184:0.519045:0.683184:0.013894:0.009827:0.014182:0.009903:0.004551:0.008104:0.008981:0.012564:0.010326:0.005866:0.004188:0.004808:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.009827:0.010357:0.004188:0.004808:0.009192:0.005866:0.003024:0.009223:0.010175:0.008981:0.010326:0.008981:0.008376:0.010326:0.003024:0.003024:0.010357:0.010326:0.005125:0.009827:0.010357:0.004188:0.004808:0.005125:0.009827:0.003024:0.009827:0.010311:0.009223:0.009903:0.009223:0.003024:0.009782:0.004188
questionnaire in more than 20 000 patients at the end of :@0.519045:0.713167:0.928000:0.713167:0.928000:0.697385:0.519045:0.697385:0.010311:0.009192:0.009827:0.005866:0.005125:0.003024:0.009903:0.009223:0.009223:0.010326:0.003024:0.004551:0.009827:0.003629:0.003024:0.009223:0.003629:0.014182:0.009903:0.004551:0.009827:0.003629:0.005125:0.009223:0.010326:0.009223:0.003629:0.008376:0.008376:0.003659:0.008376:0.008376:0.008376:0.003644:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.003644:0.010326:0.005125:0.003629:0.005125:0.009223:0.009827:0.003629:0.009827:0.009223:0.010357:0.003629:0.009903:0.004747:0.004188
the study. Cognitive function did not differ significantly :@0.519045:0.727368:0.928000:0.727368:0.928000:0.711585:0.519045:0.711585:0.005125:0.009223:0.009827:0.005292:0.005866:0.005125:0.009192:0.010357:0.008104:0.004188:0.005292:0.012292:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.005307:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.005292:0.010357:0.003024:0.010357:0.005307:0.009223:0.009903:0.005125:0.005292:0.010357:0.003024:0.004747:0.004747:0.009827:0.004551:0.005292:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.003024:0.008104:0.004188
between  patients assigned simvastatin or  those  as-:@0.519045:0.741569:0.923782:0.741569:0.923782:0.725786:0.519045:0.725786:0.010311:0.009827:0.005125:0.012564:0.009827:0.009827:0.009223:0.004188:0.005549:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.009752:0.010326:0.005866:0.005866:0.003024:0.010175:0.009223:0.009827:0.010357:0.009752:0.005866:0.003024:0.014182:0.008376:0.010326:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.009752:0.009903:0.004551:0.004188:0.005549:0.005125:0.009223:0.009903:0.005866:0.009827:0.004188:0.005549:0.010326:0.005866:0.005020
signed a placebo. The pooled results of eight long-term :@0.519045:0.755770:0.928000:0.755770:0.928000:0.739987:0.519045:0.739987:0.005866:0.003024:0.010175:0.009223:0.009827:0.010357:0.004127:0.010326:0.004127:0.010311:0.003024:0.010326:0.009782:0.009827:0.010311:0.009903:0.004188:0.004127:0.006441:0.009223:0.009827:0.004112:0.010311:0.009903:0.009903:0.003024:0.009827:0.010357:0.004127:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.004127:0.009903:0.004747:0.004112:0.009827:0.003024:0.010175:0.009223:0.005125:0.004112:0.003024:0.009903:0.009223:0.010175:0.005020:0.005125:0.009827:0.004551:0.014182:0.004188
studies, involving more than 23 000 patients, showed a :@0.519045:0.769971:0.927985:0.769971:0.927985:0.754188:0.519045:0.754188:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.004188:0.005201:0.003024:0.009223:0.008376:0.009903:0.003024:0.008376:0.003024:0.009223:0.010175:0.005216:0.014182:0.009903:0.004551:0.009827:0.005201:0.005125:0.009223:0.010326:0.009223:0.005201:0.008376:0.008376:0.005201:0.008376:0.008376:0.008376:0.005216:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.005201:0.005866:0.009223:0.009903:0.012564:0.009827:0.010357:0.005201:0.010326:0.004188
significant  reduction  (29%)  in  new-onset  dementia  in :@0.519045:0.784172:0.927985:0.784172:0.927985:0.768389:0.519045:0.768389:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.004188:0.003825:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.003810:0.005579:0.008376:0.008376:0.011717:0.005579:0.004188:0.003825:0.003024:0.009223:0.004188:0.003825:0.009223:0.009827:0.012564:0.005020:0.009903:0.009223:0.005866:0.009827:0.005125:0.004188:0.003810:0.010357:0.009827:0.014182:0.009827:0.009223:0.005125:0.003024:0.010326:0.004188:0.003825:0.003024:0.009223:0.004188
statin-treated patients, although not all  studies show :@0.519045:0.798373:0.928000:0.798373:0.928000:0.782590:0.519045:0.782590:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005020:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.008210:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.008210:0.010326:0.003024:0.005125:0.009223:0.009903:0.009192:0.010175:0.009223:0.008210:0.009223:0.009903:0.005125:0.008210:0.010326:0.003024:0.003024:0.004188:0.004037:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.008210:0.005866:0.009223:0.009903:0.012564:0.004188
changes in the same direction.  Current guidelines do :@0.519045:0.812574:0.927990:0.812534:0.927990:0.796751:0.519045:0.796791:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.005866:0.005896:0.003024:0.009223:0.005896:0.005125:0.009223:0.009827:0.005896:0.005866:0.010326:0.014182:0.009827:0.005912:0.010357:0.003024:0.004551:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004858:0.005896:0.012292:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.005881:0.010175:0.009192:0.003024:0.010357:0.009827:0.003024:0.003024:0.009223:0.009827:0.005866:0.005912:0.010357:0.009903:-0.657643
9:@0.752693:0.807235:0.757551:0.807235:0.757551:0.798081:0.752693:0.798081:0.004858
not support the prescription of statins for the sole indi-:@0.519050:0.826735:0.923817:0.826735:0.923817:0.810952:0.519050:0.810952:0.009223:0.009903:0.005125:0.005957:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125:0.005972:0.005125:0.009223:0.009827:0.005972:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.005125:0.003024:0.009903:0.009223:0.005972:0.009903:0.004747:0.005972:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.005972:0.004747:0.009903:0.004551:0.005972:0.005125:0.009223:0.009827:0.005972:0.005866:0.009903:0.003024:0.009827:0.005972:0.003024:0.009223:0.010357:0.003024:0.005020
cation of reducing the risk of dementia. statins also do :@0.519050:0.840936:0.928005:0.840936:0.928005:0.825153:0.519050:0.825153:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005004:0.009903:0.004747:0.005004:0.004551:0.009827:0.010357:0.009192:0.009782:0.003024:0.009223:0.010175:0.005004:0.005125:0.009223:0.009827:0.005004:0.004551:0.003024:0.005866:0.007590:0.005004:0.009903:0.004747:0.005004:0.010357:0.009827:0.014182:0.009827:0.009223:0.005125:0.003024:0.010326:0.004188:0.005020:0.007529:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.005004:0.010326:0.003024:0.005866:0.009903:0.005020:0.010357:0.009903:0.004188
not appear to be associated with an increased risk of :@0.519050:0.855137:0.927960:0.855137:0.927960:0.839354:0.519050:0.839354:0.009223:0.009903:0.005125:0.005700:0.010326:0.010311:0.010311:0.009827:0.010326:0.004551:0.005700:0.005125:0.009903:0.005700:0.010311:0.009827:0.005700:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.005700:0.012564:0.003024:0.005125:0.009223:0.005700:0.010326:0.009223:0.005700:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.005700:0.004551:0.003024:0.005866:0.007590:0.005700:0.009903:0.004747:0.004188
suicide or depression.:@0.519050:0.869338:0.675895:0.869338:0.675895:0.853555:0.519050:0.853555:0.005866:0.009192:0.003024:0.009782:0.003024:0.010357:0.009827:0.004188:0.009903:0.004551:0.004188:0.010357:0.009827:0.010311:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188
5:@0.675885:0.864028:0.680743:0.864028:0.680743:0.854874:0.675885:0.854874:0.004858
statin-associated muscle symptoms :@0.519047:0.900596:0.815380:0.900596:0.815380:0.882264:0.519047:0.882264:0.008735:0.005040:0.011087:0.005040:0.004032:0.010079:0.007056:0.011087:0.007392:0.007392:0.010751:0.010751:0.004032:0.011087:0.005040:0.010751:0.011087:0.004704:0.015791:0.010079:0.007392:0.010751:0.004032:0.010751:0.004704:0.007392:0.009743:0.015791:0.011087:0.005040:0.010751:0.015791:0.007392:0.004704
Muscle symptoms are by far the most frequent adverse :@0.519047:0.916966:0.927987:0.916966:0.927987:0.901184:0.519047:0.901184:0.013894:0.009192:0.005866:0.009782:0.003024:0.009827:0.004460:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004475:0.010326:0.004551:0.009827:0.004460:0.010311:0.008104:0.004460:0.004747:0.010326:0.004551:0.004460:0.005125:0.009223:0.009827:0.004460:0.014182:0.009903:0.005866:0.005125:0.004460:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.004460:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.004188
reports among statin-treated patients and are the big-:@0.519047:0.931167:0.923799:0.931167:0.923799:0.915384:0.519047:0.915384:0.004551:0.009827:0.010311:0.009903:0.004551:0.005125:0.005866:0.005110:0.010326:0.014182:0.009903:0.009223:0.010175:0.005110:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005020:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.005110:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005125:0.010326:0.009223:0.010357:0.005125:0.010326:0.004551:0.009827:0.005125:0.005125:0.009223:0.009827:0.005110:0.010311:0.003024:0.010175:0.005020
gest impediment to effective statin therapy in clinical :@0.519047:0.945368:0.928002:0.945368:0.928002:0.929585:0.519047:0.929585:0.010175:0.009827:0.005866:0.005125:0.006395:0.003024:0.014182:0.010311:0.009827:0.010357:0.003024:0.014182:0.009827:0.009223:0.005125:0.006395:0.005125:0.009903:0.006395:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.006395:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.006395:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.006395:0.003024:0.009223:0.006395:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188